{{Rsnum
|rsid=1497546
|Chromosome=3
|position=98315682
|Orientation=plus
|GMAF=0.07025
|Assembly=GRCh38
|GenomeBuild=38.1
|dbSNPBuild=141
|geno1=(A;A)
|geno2=(A;G)
|geno3=(G;G)
}}{{ population diversity
| geno1=(A;A)
| geno2=(A;G)
| geno3=(G;G)
| CEU | 0.0 | 9.7 | 90.3
| HCB | 0.0 | 1.5 | 98.5
| JPT | 0.9 | 10.6 | 88.5
| YRI | 5.4 | 40.8 | 53.7
| ASW | 7.0 | 29.8 | 63.2
| CHB | 0.0 | 1.5 | 98.5
| CHD | 0.0 | 2.8 | 97.2
| GIH | 0.0 | 11.9 | 88.1
| LWK | 3.6 | 26.4 | 70.0
| MEX | 0.0 | 0.0 | 0.0
| MKK | 1.3 | 27.9 | 70.8
| TSI | 0.0 | 5.9 | 94.1
| HapMapRevision=28
}}{{PMID Auto GWAS
|PMID=19483685
|Trait=Drug-induced liver injury (flucloxacillin)
|Title=HLA-B*5701 genotype is a major determinant of drug-induced liver injury due to flucloxacillin
|RiskAllele=
|Pval=2E-7
|OR=6.57
|ORtxt=[NR]
}}

{{GET Evidence
|impact=pathogenic
|qualified_impact=Insufficiently evaluated pathogenic
|inheritance=unknown
|quality_scores=Array
|dbsnp_id=rs1497546
|overall_frequency_n=16
|overall_frequency_d=128
|overall_frequency=0.125
|n_genomes=13
|n_genomes_annotated=0
|n_haplomes=16
|n_articles=0
|n_articles_annotated=0
|in_gwas=Y
|autoscore=2
|webscore=N
}}

{{on chip | 23andMe v1}}
{{on chip | 23andMe v2}}
{{on chip | 23andMe v3}}
{{on chip | 23andMe v4}}
{{on chip | HumanOmni1Quad}}
{{on chip | Illumina Human 1M}}